Alignment Healthcare (ALHC) to Release Earnings on Thursday

Alignment Healthcare (NASDAQ:ALHC) is scheduled to post its quarterly earnings results after the market closes on Thursday, May 2nd. Analysts expect Alignment Healthcare to post earnings of ($0.24) per share for the quarter. Alignment Healthcare has set its FY 2024 guidance at EPS and its Q1 2024 guidance at EPS.Individual interested in participating in the company’s earnings conference call can do so using this link.

Alignment Healthcare (NASDAQ:ALHC) last released its quarterly earnings data on Tuesday, February 27th. The company reported ($0.25) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.22) by ($0.03). The business had revenue of $465.39 million during the quarter, compared to analysts’ expectations of $444.56 million. Alignment Healthcare had a negative return on equity of 75.64% and a negative net margin of 8.12%. The company’s revenue was up 28.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($0.31) EPS. On average, analysts expect Alignment Healthcare to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Alignment Healthcare Trading Down 2.5 %

NASDAQ:ALHC opened at $5.08 on Tuesday. The stock has a fifty day moving average price of $5.19 and a two-hundred day moving average price of $6.58. The stock has a market capitalization of $960.02 million, a price-to-earnings ratio of -6.43 and a beta of 1.30. The company has a debt-to-equity ratio of 1.02, a quick ratio of 1.84 and a current ratio of 1.84. Alignment Healthcare has a 1 year low of $4.46 and a 1 year high of $9.20.

Insider Activity at Alignment Healthcare

In other news, CEO John E. Kao bought 103,000 shares of the business’s stock in a transaction that occurred on Thursday, March 14th. The stock was purchased at an average price of $4.82 per share, with a total value of $496,460.00. Following the purchase, the chief executive officer now owns 2,745,253 shares of the company’s stock, valued at approximately $13,232,119.46. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, CFO Robert Thomas Freeman sold 11,858 shares of the business’s stock in a transaction dated Friday, March 15th. The shares were sold at an average price of $4.89, for a total value of $57,985.62. Following the completion of the transaction, the chief financial officer now owns 898,228 shares of the company’s stock, valued at approximately $4,392,334.92. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO John E. Kao bought 103,000 shares of the business’s stock in a transaction that occurred on Thursday, March 14th. The stock was purchased at an average cost of $4.82 per share, with a total value of $496,460.00. Following the purchase, the chief executive officer now directly owns 2,745,253 shares in the company, valued at approximately $13,232,119.46. The disclosure for this purchase can be found here. In the last quarter, insiders sold 90,213 shares of company stock valued at $460,587. 6.30% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on the company. Piper Sandler reiterated a “neutral” rating and issued a $6.00 price objective (down previously from $12.00) on shares of Alignment Healthcare in a research report on Wednesday, March 6th. William Blair reiterated an “outperform” rating on shares of Alignment Healthcare in a research report on Wednesday, March 6th. Stifel Nicolaus dropped their price target on Alignment Healthcare from $11.00 to $9.00 and set a “buy” rating for the company in a research report on Tuesday, April 23rd. UBS Group dropped their price target on Alignment Healthcare from $9.00 to $8.50 and set a “neutral” rating for the company in a research report on Wednesday, February 28th. Finally, Raymond James raised their price target on Alignment Healthcare from $10.00 to $12.00 and gave the company a “strong-buy” rating in a research report on Tuesday, January 9th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating, three have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $9.18.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.